semaglutide phase 3 SUSTAIN trials included in the analyses with Phase 3 ESSENCE trial: Semaglutide

The US Food and Drug Administration (FDA) requires any chronic weight management medication that works on the central nervous system to carry a warning about suicidal behavior and ideation

The Research Ethics Committee of the School of Medicine - Shiraz University of Medical Sciences granted approval for the present study with the ethics code of IR.SUMS.MED.REC.1403.134

In clinical trials, these medications have produced significant results

10 Vitamin D and calcium Rapid weight loss can impact bone density

CVS Caremark requires BMI 30+ (or 27+ with weight-related comorbidity), documented failure of a supervised diet and exercise program for 3 to 6 months, recent weight measurement, and screening for contraindications